CompletedNCT03000387
Personalized Nicotine Replacement Dosing for Smoking Cessation
About this title
Read the official source — NCT03000387Medication studyAges 18–75CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 75 years.
- Listed locations
- Ottawa and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: January 23, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 211
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT03000387
- Official title
Show the full official title
Personalized Dosing of Nicotine Replacement for Smoking Cessation: An Effectiveness Randomized Placebo-controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ottawa · Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Nicotine Patch and Placebos.
Who was this study for?
Listed age limits: 18 years to 75 years.
